1-10 of 10
Robert Deuson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparing the Cost Per Treatment Success of Thrombopoietin Receptor Agonists to Watch & Rescue for the Treatment of Primary Adult Chronic Immune Thrombocytopenia (ITP) in the US

Kelly Northridge, MBA, MPH, Mark Danese, PhD, Robert Deuson, PhD
Journal: Blood
Blood (2012) 120 (21): 4640.
https://doi.org/10.1182/blood.V120.21.4640.4640
Published: 2012
Journal Articles

Clinical and Economic Outcomes Associated with Emergency Department Visits in Patients with Immune Thrombocytopenia,

Z John Lu, PhD, Mark D. Danese, MHS, PhD, Marc Halperin, Melissa Eisen, MD, Robert Deuson, PhD
Journal: Blood
Blood (2011) 118 (21): 4209.
https://doi.org/10.1182/blood.V118.21.4209.4209
Published: 2011
Journal Articles

Comparative Net Cost Impact of the Utilization of Romiplostim and Intravenous Immunoglobulin for the Treatment of Patients with Immune Thrombocytopenia in Quebec,

Martine Pettigrew, Robert Deuson, PhD, Kirsten Garces
Journal: Blood
Blood (2011) 118 (21): 4211.
https://doi.org/10.1182/blood.V118.21.4211.4211
Published: 2011
Journal Articles

Hospitalizations in Pediatric Patients with Immune Thrombocytopenia

Z John Lu, PhD, Mark D. Danese, MHS, PhD, Robert Herbert, Melissa Eisen, MD, Robert Deuson, PhD
Journal: Blood
Blood (2011) 118 (21): 170.
https://doi.org/10.1182/blood.V118.21.170.170
Published: 2011
Journal Articles

Patient Quality of Life (QOL) In Nonsplenectomized Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim or Medical Standard of Care (SOC)

Mathias J. Rummel, MD, PhD, David J. Kuter, MD, DPhil, Romeo Mandanas, MD, Aristoteles Giagounidis, MD, Xuena Wang, PhD, Susan D. Mathias, MPH, Robert Deuson, PhD
Journal: Blood
Blood (2010) 116 (21): 569.
https://doi.org/10.1182/blood.V116.21.569.569
Published: 2010
Journal Articles

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving Romiplostim or Medical Standard of Care.

Roberto Stasi, MD, Magaral Murali, Marc Michel, Jean-Francois Viallard, MD, PhD, Aristoteles Giagounidis, Ann Janssens, MD, Jason Legg, Mark Danese, Robert Deuson, PhD
Journal: Blood
Blood (2009) 114 (22): 1311.
https://doi.org/10.1182/blood.V114.22.1311.1311
Published: 2009
Journal Articles

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim in Two Phase 3 Placebo-Controlled Clinical Trials.

Ilene Ceil Weitz, MD, Miguel A Sanz, David H. Henry, MD, Martin Schipperus, Bertrand Godeau, Michelle Gleeson, PhD, Mark Danese, Robert Deuson, PhD
Journal: Blood
Blood (2009) 114 (22): 891.
https://doi.org/10.1182/blood.V114.22.891.891
Published: 2009
Journal Articles

Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Treatment Pattern and Splenectomy Rate from a Multinational Prospective Observational Study

Francesco Rodeghiero, MD, Axel C. Matzdorff, MD, Tiziano Barbui, MD, Jean- Francois Viallard, MD, PhD, Naveed M. Chowhan, MD, Robert Robles, MD, Boriana Kamenova, MD, Ze Cong, MS, Robert Deuson, PhD, John J. Isitt, MS
Journal: Blood
Blood (2008) 112 (11): 4538.
https://doi.org/10.1182/blood.V112.11.4538.4538
Published: 2008
Journal Articles

Initial and Long-Term Outcomes of Splenectomy in Adult Immune Thrombocytopenic Purpura (ITP) Patients: A Systematic Review and Meta-Analysis.

Joseph Mikhael, Craig M. Kessler, Mark Danese, Robert Deuson
Journal: Blood
Blood (2007) 110 (11): 1321.
https://doi.org/10.1182/blood.V110.11.1321.1321
Published: 2007
Journal Articles

The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndrome (MDS).

Hagop M. Kantarjian, MD, Francis Giles, MD, FRCPI, FRCPath, Alan F. List, MD, Roger Lyons, MD, Sherry Price, BSN, Robert Deuson, PhD, Joseph Leveque, MD
Journal: Blood
Blood (2006) 108 (11): 2617.
https://doi.org/10.1182/blood.V108.11.2617.2617
Published: 2006